Access New Active Substance and Biosimilar Work Sharing Initiatives
The New Active Substance Work Sharing Initiative has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative builds on this success.
Read the updated guidance from Medicines and Healthcare products Regulatory Agency published on 1st August 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (12 août 2024). Access New Active Substance and Biosimilar Work Sharing Initiatives. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/125vf





